Osler Diagnostics

Osler Diagnostics is an early-stage, private company developing a transformative, portable point-of-care diagnostic system called the Osler Origin®. The platform consolidates multiple tests onto a single, low-cost instrument using proprietary microfluidics and electrochemical biosensing technology, aiming to decentralize lab-quality testing. Led by a seasoned executive team with deep diagnostics industry experience and backed by prominent venture capital, Osler is positioned to target a significant global market opportunity across emergency, primary, and retail care settings. The company is currently in the development and industrialization phase, building towards product launch and commercialization.

Integrated 'lab-in-your-hand' platform combining proprietary Osler HemaTap® sample addition, microfluidic sample preparation, and electrochemical biosensing for portable, quantitative, multiplexed diagnostics.

Osler competes in the crowded point-of-care diagnostics market dominated by large players like Abbott, Roche, Siemens Healthineers, and QuidelOrtho. Its differentiation hinges on offering lab-quality, multiplexed, quantitative results on a single, portable platform, a value proposition aimed at consolidating multiple existing single-analyte systems.